Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo¹H MR Spectroscopy—A Pilot Study at 4 T

Abstract

These results suggest that the change in tCho concentration between baseline and 24 hours after the first dose of PST can serve as an indicator for predicting clinical response to doxorubicin-based chemotherapy in locally advanced breast cancer.